Deborah H. McCollister

发表

Development of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT®) questionnaire: a new patient-reported outcome instrument for PAH

I. Wiklund, D. Badesch, A. Peacock, 2016, Respiratory Research.

The Potential for Therapeutic Misconception in Pulmonary Arterial Hypertension Clinical Trials: A Case-Based Discussion

D. Badesch, T. Bull, Deborah H. McCollister, 2010 .

Use of selective serotonin reuptake inhibitors and outcomes in pulmonary arterial hypertension.

H. Farber, N. Hill, Deborah H. McCollister, 2010, Chest.

Depressive symptoms in pulmonary arterial hypertension: prevalence and association with functional status.

J. Rumsfeld, D. Badesch, F. Masoudi, 2010, Psychosomatics.

Depressive symptoms in pulmonary arterial hypertension: prevalence and association with functional status.

J. Rumsfeld, D. Badesch, F. Masoudi, 2010, Psychosomatics.

Depression and Pulmonary Arterial Hypertension: Should We be Screening for Depressive Symptoms?

Deborah H. McCollister, P. Weintraub, 2010 .

Depression: Beyond Description As an Important Comorbidity in Pulmonary Arterial Hypertension—The Next Steps

D. Badesch, Deborah H. McCollister, P. Weintraub, 2012 .

Screening pulmonary hypertension patients for depression

Deborah H. McCollister, Deborah H. McCollister, 2011, International journal of clinical practice. Supplement.

Development of a new patient-reported outcome (PRO) instrument for pulmonary arterial hypertension (PAH): The pulmonary arterial hypertension–symptoms and impact (PAH-SYMPACT) questionnaire

I. Wiklund, D. Badesch, Deborah H. McCollister, 2013 .